IDEX Corporation's Valuation Is Too High Even With Strong Growth

IDEX Corporation has outperformed the S&P 500, with shares up 21.4% since November, driven by rising revenue, profits, and cash flow. IEX remains diversified across industries, with recent growth in Health & Science Technologies fueled by acquisitions and organic gains in semiconductors and aviation. Despite recent gains, IEX appears fairly valued on an absolute basis but trades at a discount relative to peers; a 'hold' rating is maintained.